FDA Inspection
Leila Chaychi, M.D.Leila Chaychi, M.D. – FDA Inspection, Oct 22, 2021
Record Details
This FDA Inspection record concerns Leila Chaychi, M.D., with an inspection on October 22, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Leila Chaychi, M.D.
- Inspection Date
- October 22, 2021
- Product Type
- Drugs
View Company Profile
ID · 7d6a01c6-3864-4e1b-a733-832f66b03d9c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1155162
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 50.27(a)Consent form not approved/signed/dated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Leila Chaychi, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 1, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Leila Chaychi, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.